Palisade Bio (PALI) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.56% |
| Dec 31, 2025 | 3,928.02% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | -50.85% |
| Mar 31, 2025 | -28.84% |
| Dec 31, 2024 | 13.38% |
| Sep 30, 2024 | -33.58% |
| Jun 30, 2024 | -1.14% |
| Mar 31, 2024 | -11.04% |
| Dec 31, 2023 | -19.66% |
| Sep 30, 2023 | -10.87% |
| Jun 30, 2023 | 14.93% |
| Mar 31, 2023 | 10.16% |
| Dec 31, 2022 | 0.39% |
| Sep 30, 2022 | 195.18% |
| Jun 30, 2022 | -12.12% |
| Mar 31, 2022 | -34.94% |
| Dec 31, 2021 | 87.88% |
| Sep 30, 2021 | 141.51% |
| Jun 30, 2021 | 52.93% |
| Mar 31, 2021 | -20.85% |
| Dec 31, 2020 | -29.23% |
| Sep 30, 2020 | -10.01% |
| Jun 30, 2020 | -14.17% |
| Mar 31, 2020 | -22.77% |
| Dec 31, 2019 | -218.31% |
| Sep 30, 2019 | 258.83% |
| Jun 30, 2019 | -40.01% |
| Mar 31, 2019 | -45.92% |
| Dec 31, 2018 | 35.06% |
| Sep 30, 2018 | -27.47% |
| Jun 30, 2018 | -6.54% |
| Mar 31, 2018 | -22.41% |
| Dec 31, 2017 | -26.37% |
| Sep 30, 2017 | 50.33% |
| Jun 30, 2017 | -21.34% |
| Mar 31, 2017 | -13.69% |
| Dec 31, 2016 | 399.36% |
| Sep 30, 2016 | -552.48% |
| Jun 30, 2016 | 593.83% |
| Mar 31, 2016 | -103.41% |
| Dec 31, 2015 | -44.21% |
| Sep 30, 2015 | -38.77% |
| Jun 30, 2015 | -24.91% |
| Mar 31, 2015 | 9.27% |
| Dec 31, 2014 | -15.23% |
| Sep 30, 2014 | -13.00% |
| Jun 30, 2014 | -10.66% |
| Mar 31, 2014 | 219.51% |
| Dec 31, 2013 | 1.83% |
| Sep 30, 2013 | 87.35% |
| Jun 30, 2013 | -22.50% |
| Mar 31, 2013 | -18.34% |
| Dec 31, 2012 | -23.36% |
| Sep 30, 2012 | 265.62% |
| Jun 30, 2012 | -45.12% |
| Mar 31, 2012 | 173.18% |
| Dec 31, 2011 | -57.47% |
| Sep 30, 2011 | -37.72% |